Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
5.57
-0.06 (-1.07%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Zura Bio Employees
Zura Bio had 40 employees as of December 31, 2025. The number of employees increased by 10 or 33.33% compared to the previous year.
Employees
40
Change (1Y)
10
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,911,125
Market Cap
533.77M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 40 | 10 | 33.33% | 40 | 0 |
| Dec 31, 2024 | 30 | 15 | 100.00% | 30 | 0 |
| Dec 31, 2023 | 15 | - | - | 14 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Prime Medicine | 146 |
| MapLight Therapeutics | 133 |
| Artiva Biotherapeutics | 115 |
| Adlai Nortye | 109 |
| Prelude Therapeutics | 79 |
| Altimmune | 57 |
| Ovid Therapeutics | 23 |
ZURA News
- 4 days ago - Zura Bio Slides: Corporate presentation - Filings
- 4 days ago - Zura Bio reports Q2 EPS (21c), consensus (19c) - TheFly
- 4 days ago - Zura Bio sees cash runway through the end of 2028 - TheFly
- 4 days ago - Zura Bio Reports Second Quarter 2026 Financial Results and Recent Corporate Updates - Business Wire
- 4 days ago - Zura Bio Quarterly report: Q2 2026 - Filings
- 4 days ago - Zura Bio Earnings release: Q2 2026 - Filings
- 5 weeks ago - Zura Bio initiated with an Outperform at William Blair - TheFly
- 6 weeks ago - Zura Bio Slides: Corporate presentation - Filings